Evidence map›Paper›PMID 35103495›Full record

Observational studyJournal of intensive care medicine2022

Early Post-Hospitalization Hemoglobin Recovery and Clinical Outcomes in Survivors of Critical Illness: A Population-Based Cohort Study.

Matthew A Warner, Andrew C Hanson, Phillip J Schulte, Nareg H Roubinian, Curt Storlie, Gabriel Demuth, Ognjen Gajic, Daryl J Kor

Open access · greenAbstract readObservational Study
In one paragraph

Observational study in Journal of intensive care medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Iron and erythropoietin to heal and recover after intensive care (ITHRIVE): A pilot randomised clinical trial.Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine · 2023
    Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Matthew A Warner6915Mayo Clinic, Rochester, MN, USA.ORCID https://orcid.org/0000-0002-6625-8755
Andrew C Hanson6915Mayo Clinic, Rochester, MN, USA.
Phillip J Schulte6915Mayo Clinic, Rochester, MN, USA.
Nareg H Roubinian166672Vitalant Research Institute, San Francisco, CA, USA.
Curt Storlie6915Mayo Clinic, Rochester, MN, USA.
Gabriel Demuth6915Mayo Clinic, Rochester, MN, USA.
Ognjen Gajic6915Mayo Clinic, Rochester, MN, USA.
Daryl J Kor6915Mayo Clinic, Rochester, MN, USA.
Mayo Clinic in Arizona · USKaiser Permanente · US

Funding

ZESTRIL VS. VERAPAMIL IN THE TREATMENT OF HYPERTENSIONM01RR000585 · NCRR · MAYO CLINIC ROCHESTER · PI RIZZA, ROBERT A. · 1985 to 2006
$30.4M
Institutional Career Development CoreKL2TR002379 · NCATS · MAYO CLINIC ROCHESTER · PI NILUFER ERTEKIN-TANER · 2017 to 2026
$14.9M
Secondary use of EMRs for surgical complication surveillanceR01EB019403 · NIBIB · MAYO CLINIC ROCHESTER · PI LIU, HONGFANG, STORLIE, CURTIS · 2015 to 2022
$3.8M
Interdisciplinary Infrastructure for Aging Research: Rochester Epidemiology ProjectR33AG058738 · NIA · MAYO CLINIC ROCHESTER · PI LEBRASSEUR, NATHAN K, OLSON, JANET E · 2020 to 2022
$2.4M
Attenuation of Anemia for the Optimization of Post-Hospitalization Functional Recovery in Survivors of Critical IllnessK23HL153310 · NHLBI · MAYO CLINIC ROCHESTER · PI WARNER, MATTHEW A · 2021 to 2025
$909k
NCATS NIH HHS KL2 TR002379NCRR NIH HHS M01 RR000585NHLBI NIH HHS K23 HL153310NIA NIH HHS R33 AG058738NIBIB NIH HHS R01 EB019403
6 · The paper itself

Abstract

Anemia is common during critical illness, is associated with adverse clinical outcomes, and often persists after hospitalization. The goal of this investigation is to assess the relationships between post-hospitalization hemoglobin recovery and clinical outcomes after survival of critical illness. This is a population-based observational study of adults (≥18 years) surviving hospitalization for critical illness between January 1, 2010 and December 31, 2016 in Olmsted County, Minnesota, United States with hemoglobin concentrations and clinical outcomes assessed through one-year post-hospitalization. Multi-state proportional hazards models were utilized to assess the relationships between 1-month post-hospitalization hemoglobin recovery and hospital readmission or death through one-year after discharge. Among 6460 patients that survived hospitalization for critical illness during the study period, 2736 (42%) were alive, not hospitalized, and had available hemoglobin concentrations assessed at 1-month post-index hospitalization. Median (interquartile range) age was 69 (56, 80) years with 54% of male gender. Overall, 86% of patients had anemia at the time of hospital discharge, with median discharge hemoglobin concentrations of 10.2 (9.1, 11.6) g/dL. In adjusted analyses, each 1 g/dL increase in 1-month hemoglobin recovery was associated with decreased instantaneous hazard for hospital readmission (HR 0.87 [95% CI 0.84-0.90]; p < 0.001) and lower mortality (HR 0.82 [95% CI 0.75-0.89]; p < 0.001) through one-year post-hospitalization. The results were consistent in multiple pre-defined sensitivity analyses. Impaired early post-hospitalization hemoglobin recovery is associated with inferior clinical outcomes in the first year of survival after critical illness. Additional investigations are warranted to evaluate these relationships.

Indexed as

AnemiaCritical IllnessAdultAgedAged, 80 and overCohort StudiesFemaleHemoglobinsHospitalizationHumansMaleMiddle AgedSurvivorsUnited StatesHemoglobinsanemiacritical illnesshemoglobinintensive carereadmissiontransfusion

Identifiers

PMID35103495
PMCPMC9339589
OpenAlexW4210815001

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.